Archives

  • Certara Announces the Availability of PK Submit, its Pharmacokinetic CDISC Technology Solution

    Certara®, the global model-informed drug development and decision support leader, today announced the availability of PK Submit™, a technology solution

    Read More
  • PTC Therapeutics Launches A No-Cost Testing Program to Drive AADC Deficiency Patient Identification

    PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the launch of a no-cost testing program for aromatic L-amino acid decarboxylase (AADC)

    Read More
  • Unichem Labs Gets USFDA Nod To Market Anxiety Disorder Tablets

    Drug firm Unichem Laboratories on Friday said it has received approval from the US health regulator to market its generic Buspirone Hydrochloride

    Read More
  • Exposure to HIV drug in the womb may increase risk of microcephaly, developmental delays in children

    Children born to women on HIV therapy containing the drug efavirenz were 2 to 2.5 times more likely to have

    Read More
  • Panacea Biotec appoints Rajeeva Kumar Mangalum as Chief Operating Officer for pharmaceutical operations

    As part of its organisational restructuring programme, drug firm Panacea BiotecNSE 0.95 % on Tuesday said it has appointed Susheel

    Read More

Archive

Offers